Eligi
Med
Ensayos clínicos
Suscripción
Sobre EligiMed
Ensayos Clínicos de Endocrinología | EligiMed
Ensayos clínicos
8.676 ensayos encontrados
Completado
Fase 3
ClinicalTrials.gov
An 18-Month Double-Blind, Placebo-Controlled, Phase III, Trial With a 12-Month Interim Analysis of the Effect of Recombinant Human Parathyroid Hormone (ALX1-11) on Fracture Incidence in Women With Postmenopausal Osteoporosis
INTERVENTIONAL
Inicio: 27 de abr de 2000
ID: NCT00172081
Reclutando
Fase 3
ClinicalTrials.gov
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo As Maintenance Therapy After First Line Induction Therapy in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast Cancer
INTERVENTIONAL
Inicio: 8 de sept de 2023
ID: NCT05894239
Completado
Fase 3
ClinicalTrials.gov
A Pivotal, Open-Label, Parallel Study to Evaluate the Safety and Efficacy of Human Insulin Inhalation Powder (HIIP) Compared to Injectable Insulin in Patients With Diabetes and COPD or Asthma
INTERVENTIONAL
Inicio: 1 de ago de 2005
ID: NCT00157339
Terminado
Fase 3
ClinicalTrials.gov
A 46-week, Double-blind, Placebo-controlled, Phase 3 Study With a 6-week Randomized-withdrawal Period to Evaluate the Safety and Efficacy of Relamorelin in Patients With Diabetic Gastroparesis
INTERVENTIONAL
Inicio: 24 de ene de 2018
ID: NCT03420781
Completado
ClinicalTrials.gov
The Effect of NovoMix® 30, Levemir® or NovoRapid® (Alone or in Combination) in Subjects With Type 2 Diabetes Previously Treated With Other Anti-diabetic Medication. A 24-week, International, Prospective, Multi-centre, Open-labelled, Non-interventional Study
OBSERVATIONAL
Inicio: 1 de nov de 2008
ID: NCT00869908
Completado
Fase 3
ClinicalTrials.gov
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Cardiovascular Outcomes Following Treatment With Alogliptin in Addition to Standard of Care in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
INTERVENTIONAL
Inicio: 1 de sept de 2009
ID: NCT00968708
Completado
Fase 4
ClinicalTrials.gov
A Long Term, Randomised, Double Blind, Placebo-controlled Study to Determine the Effect of Albiglutide, When Added to Standard Blood Glucose Lowering Therapies, on Major Cardiovascular Events in Patients With Type 2 Diabetes Mellitus
INTERVENTIONAL
Inicio: 1 de jul de 2015
ID: NCT02465515
Completado
Fase 2
ClinicalTrials.gov
Phase 2 Clinical Trial of Bi-weekly Dosing of Irofulven Plus Capecitabine in Patients With Anaplastic or Locally Advanced/Metastatic Differentiated Thyroid Cancer
INTERVENTIONAL
Inicio: 31 de mar de 2005
ID: NCT00124527
Reclutando
Fase 3
ClinicalTrials.gov
A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of Once Weekly Eloralintide in Adult Participants With Obesity or Overweight, Without Type 2 Diabetes
INTERVENTIONAL
Inicio: 6 de feb de 2026
ID: NCT07321886
Completado
Fase 3
ClinicalTrials.gov
A 4-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial To Evaluate The Efficacy And Safety Of Saxagliptin In Comparison To Placebo As Add On Treatment To Metformin XR In Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control With Diet And Exercise And A Stable Dose Of Metformin ≥1500 mg/Day
INTERVENTIONAL
Inicio: 1 de jul de 2008
ID: NCT00683657
Terminado
Fase 3
ClinicalTrials.gov
An Open Label, Multi-Center, Long-Term Extension Study to Evaluate the Safety of PHX1149T/Dutogliptin in Subjects With Type 2 Diabetes Mellitus
INTERVENTIONAL
Inicio: 1 de mar de 2009
ID: NCT00865592
Reclutando
Fase 2
ClinicalTrials.gov
An Open-label, Long-term Extension Study to Evaluate Safety and Efficacy in Participants Treated With CRN04894
INTERVENTIONAL
Inicio: 25 de feb de 2025
ID: NCT06712823
Completado
Fase 3
ClinicalTrials.gov
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial of Lenvatinib (E7080) in 131I-Refractory Differentiated Thyroid Cancer
INTERVENTIONAL
Inicio: 17 de mar de 2011
ID: NCT01321554
Completado
ClinicalTrials.gov
Observational and Cross-Sectional Cohort Study of the Natural History and Phenotypic Spectrum of Farber Disease
OBSERVATIONAL
Inicio: 22 de nov de 2017
ID: NCT03233841
Anterior
1
...
34
35
36
...
434
Siguiente
Filtros